Bellerophon Appoints Ted Wang, Ph.D., of Puissance Capital Management, to its Board of Directors
Nov 30, 2017 22:46 pm UTC| Business
WARREN, N.J., Nov. 30, 2017 -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the appointment of Ted Wang, Ph.D., Chief Investment Officer of Puissance Capital...
Nov 30, 2017 22:25 pm UTC| Business
STEVENSON, Md., Nov. 30, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the...
Nov 30, 2017 22:25 pm UTC| Business
STEVENSON, Md., Nov. 30, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the...
Nov 30, 2017 22:15 pm UTC| Business
BOCA RATON, Fla., Nov. 30, 2017 -- Dawson James Securities, Inc. in conjunction with Skyline Medical Inc. closed a private placement of a newly created series of preferred stock designated as “Series C Convertible...
Nov 30, 2017 22:14 pm UTC| Business
STEVENSON, Md., Nov. 30, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the...
Nov 30, 2017 22:13 pm UTC| Business
STEVENSON, Md., Nov. 30, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the...
Contango Provides Corporate and Operational Update
Nov 30, 2017 22:12 pm UTC| Business
HOUSTON, Texas, Nov. 30, 2017 -- Contango Oil Gas Company (NYSE MKT:MCF) (“Contango”) announced today an update on corporate activity and operations on its Southern Delaware Basin acreage in Pecos County, Texas. ...
UK Inflation Stabilizes: November CPI at 2.6%, Signaling Economic Recovery
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update